# Study of the Safety and Tolerability of AXA1125 and AXA1957 in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)

> **NCT04073368** · NA · COMPLETED · sponsor: **Axcella Health, Inc** · enrollment: 112 (actual)

## Conditions studied

- NAFLD

## Interventions

- **DIETARY_SUPPLEMENT:** AXA1957
- **DIETARY_SUPPLEMENT:** AXA1125
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04073368
- **Lead sponsor:** Axcella Health, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-03
- **Primary completion:** 2020-03-31
- **Final completion:** 2020-09-03
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2021-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04073368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04073368, "Study of the Safety and Tolerability of AXA1125 and AXA1957 in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04073368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*